Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Abbreviated new drug applications (ANDAs) are the submission required in the US to launch a generic version of an existing approved medicine. They are called abbreviated because fresh data on animal and human clinical studies is not required. Rather, the onus is on the producer to demonstrate bioequivalence to the reference product.
